New Study on Fatigue in Craniopharyngioma Survivors
Raymond A. Wood Foundation and Rhythm Pharmaceuticals Partner to Study Fatigue in Craniopharyngioma Survivors Fatigue ... Read more
Shedding Light on the Health Challenges of Craniopharyngioma Survivors
New Insights from the Hypothalamic-Pituitary Brain Tumor Patient Registry Craniopharyngioma (CP) survivors face a range ... Read more
Understanding Data Security in the Hypothalamic-Pituitary Brain Tumors Patient Registry
When it comes to sharing personal health information, concerns about data security are paramount, especially ... Read more
Updates on Current and Pending Hypothalamic Obesity Clinical Trials
We are pleased to share updates on several clinical trials focusing on hypothalamic obesity (HO), ... Read more
The Raymond A. Wood Foundation and NORD® Launch Natural History Study of Rare Hypothalamic-Pituitary Brain tumors.
Research study is open to participants worldwide to advance understanding and treatments these rare diseases ... Read more
Illuminating Insights: Sharing a Recent Commentary on Our Research
The Raymond A. Wood Foundation is honored to share a significant development in our journey ... Read more
Clinical Trial Participant Best Practices
As a Participant, it’s Important to Do Your Part to Maintain the Integrity of the ... Read more
Innovating in Diabetes Insipidus Management: A Breakthrough in Blood Sodium Testing
Introduction Managing diabetes insipidus just got a significant boost, thanks to the groundbreaking work of ... Read more
Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study
The Raymond A. Wood Foundation recently published its first research study entitled “Caregiver burden and ... Read more
Development of Patient Registry Well Underway
The Raymond A. Wood Foundation hosted our first International Hypothalamic-Pituitary Brain Tumor Patient Registry advisory ... Read more
